结果页面 11，板块：医疗保健，行业：生物技术，股市 - 报价与价格
包含价格、市值、市盈率和每股收益的所有股票清单
所有国家
所有交流
- {{item.name}}
- 所有交流
- Amsterdam (3)
- ASX (58)
- Brussels (7)
- BSE (9)
- Canadian Sec (30)
- Cboe CA (4)
- Copenhagen (6)
- Dusseldorf (1)
- Frankfurt (648)
- Helsinki (4)
- HKSE (46)
- IOB (25)
- Irish (1)
- Istanbul (1)
- KOSDAQ (2)
- KSE (10)
- LSE (44)
- MCE (4)
- MCX (2)
- Mexico (28)
- Milan (4)
- Munich (27)
- Nasdaq (1)
- NasdaqCM (285)
- NasdaqGM (149)
- NasdaqGS (226)
- NSE (10)
- NYSE (10)
- NYSE American (19)
- NZSE (1)
- Oslo (14)
- OTC Markets EXMKT (112)
- OTC Markets OTCPK (125)
- OTC Markets OTCQB (38)
- OTC Markets OTCQX (8)
- Other OTC (39)
- Paris (41)
- São Paulo (16)
- Shanghai (47)
- Shenzhen (47)
- Stockholm (70)
- Stuttgart (39)
- Swiss (11)
- Taipei Exchange (59)
- Taiwan (8)
- Tel Aviv (19)
- Thailand (2)
- Tokyo (37)
- Toronto (19)
- TSXV (30)
- Vienna (16)
- Warsaw (9)
- XETRA (23)
医疗保健 (2611)
- {{item.name}}
- 所有版块
- 医疗保健 (2611)
生物技术 (2611)
| 名称 名称 | 价格 价格 |
24h% 7d chart 24h% & 7d |
市值 市值 | 交易量 交易量 | 低24小时 | 高24小时 | 市值 | 市盈率 | 每股收益 |
|---|
| 名称 名称 | 价格 价格 |
24h% 7d chart 24h% & 7d |
市值 市值 | 交易量 交易量 | 低24小时 | 高24小时 | 市值 | 市盈率 | 每股收益 | |
|---|---|---|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.pe }} | {{ item.eps }} {{ item.eps_usd }} | |
| Neutra NTRR | $0.0002 — |
0
|
$583.58K — | $3.69M — | $0.0002 — | $0.0002 — | $583.58K — | 0 | $0 — | |
| Nova Mentis Life Science NMLSF | $0.02999 — |
0
|
$580.06K — | $10K — | $0.02999 — | $0.02999 — | $580.06K — | 0 | -$0.14 — | |
| Bonus BioGroup Ltd. BONS.TA | $16.6 0.05 USD |
-0.6
|
$193.88M 565.34K USD | $141.34K 412.13 USD | $16.6 0.05 USD | $16.7 0.05 USD | $193.88M 565.34K USD | 0 | -$0.04 -0.0001 USD | |
| Syros Pharmaceuticals SYRS | $0.02 — |
-23.08
|
$536.65K — | $137.57K — | $0.02 — | $0.02999 — | $536.65K — | 0 | -$3.07 — | |
| Doseology Sciences Inc. MOOD.CN | $0.16 0.12 USD |
0
|
$720.08K 534.34K USD | $3.75K 2.78K USD | $0.16 0.12 USD | $0.16 0.12 USD | $720.08K 534.34K USD | 0 | -$0.06 -0.04 USD | |
| Oxurion NV OXUR.BR | $0.1 0.11 USD |
+4.21
|
$458.83K 501.56K USD | $7.78K 8.51K USD | $0.08999 0.09 USD | $0.1 0.11 USD | $458.83K 501.56K USD | 0.0010 | $97.53 106.61 USD | |
| NanoSphere Health Sciences Inc. NSHS.CN | $0.05999 0.04 USD |
0
|
$616.51K 457.49K USD | $99 73.46 USD | $0.05999 0.04 USD | $0.05999 0.04 USD | $616.51K 457.49K USD | 0 | -$0.01 -0.007 USD | |
| Nascent Biotech NBIO | $0.002299 — |
0
|
$396.1K — | $43K — | $0.002299 — | $0.0025 — | $396.1K — | 0 | $0 — | |
| Wesana Health WSNAF | $0.02 — |
0
|
$388.07K — | $3K — | $0.04 — | $0.04 — | $388.07K — | 0 | -$0.02 — | |
| Amarantus BioScience AMBS | $0.0005 — |
0
|
$315.2K — | $100.1K — | $0.0001 — | $0.0001 — | $315.2K — | 0 | -$0.04 — | |
| CNBX Pharmaceuticals CNBX | $0.009599 — |
+1.05
|
$298.67K — | $10K — | $0.009599 — | $0.009599 — | $298.67K — | 0 | -$0.01 — | |
| Scandion Oncology A/S SCOL.ST | $0.01 0.0011 USD |
-5
|
$2.68M 261.24K USD | $1.96M 191.57K USD | $0.01 0.00099 USD | $0.01 0.0012 USD | $2.68M 261.24K USD | 0 | -$0.24 -0.02 USD | |
| Virpax Pharmaceuticals VRPX | $0.2099 — |
0
|
$260.92K — | $5.84K — | $0.2099 — | $0.25 — | $260.92K — | 0 | -$71 — | |
| TransCode Therapeutics RNAZ | $0.3599 — |
-10.4
|
$248.28K — | $2.33M — | $0.3499 — | $0.4 — | $248.28K — | 0.000063 | $5.57K — | |
| GlobeStar Therapeutics GSTC | $0.0002 — |
0
|
$248.22K — | $5.66M — | $0.0002 — | $0.0002 — | $248.22K — | 0 | $0 — | |
| Mera Pharmaceuticals MRPI | $0.0001 — |
0
|
$222.92K — | $4.42M — | $0.0001 — | $0.0001 — | $222.92K — | 0 | $0 — | |
| Endonovo Therapeutics ENDV | $0.0002 — |
0
|
$219.58K — | $8M — | $0.0002 — | $0.0002 — | $219.58K — | 0 | $0 — | |
| Kiromic BioPharma KRBP | $0.08 — |
0
|
$214.93K — | $42.93K — | $0.1799 — | $0.3099 — | $214.93K — | 0 | -$3.17 — | |
| Neovacs S.A. ALNEV.PA | $0.02 0.02 USD |
-8.47
|
$163.21K 178.41K USD | $2.8M 3.07M USD | $0.02 0.02 USD | $0.02999 0.03 USD | $163.21K 178.41K USD | 0 | -$37,997 -41536.07 USD | |
| BioLineRx Ltd. BLRX.TA | $1.6 0.0046 USD |
-5.88
|
$35.72M 104.16K USD | $3.32M 9.68K USD | $1.6 0.0046 USD | $1.7 0.0049 USD | $35.72M 104.16K USD | 0 | -$0.04 -0.0001 USD | |
| Innovation Pharmaceuticals IPIX | $0.0002 — |
0
|
$103.67K — | $3K — | $0.0002 — | $0.0002 — | $103.67K — | 0 | -$0.01 — | |
| Can-Fite BioPharma Ltd. CANF.TA | $1.7 0.0049 USD |
-5.56
|
$31.09M 90.66K USD | $16.32M 47.58K USD | $1.6 0.0046 USD | $1.7 0.0049 USD | $31.09M 90.66K USD | 0 | -$0.03 -0.00008 USD | |
| GB Sciences GBLX | $0.0002 — |
0
|
$81.41K — | $250 — | $0.0002 — | $0.0002 — | $81.41K — | 0 | $0 — | |
| U.S. Stem Cell USRM | $0.0001 — |
0
|
$64.15K — | $10.99K — | $0.0001 — | $0.0001 — | $64.15K — | 0 | $0 — | |
| Better Therapeutics BTTX | $0.0002999 — |
+50
|
$16.36K — | $151 — | $0.0002999 — | $0.0002999 — | $16.36K — | 0 | -$1.1 — | |
| Q BioMed QBIO | $0.0001 — |
0
|
$14.51K — | $1K — | $0.0001 — | $0.0001 — | $14.51K — | 0 | -$0.02 — | |
| Statera Biopharma STAB | $0.0001 — |
0
|
$7.14K — | $600 — | $0.0001 — | $0.0001 — | $7.14K — | 0 | -$2.36 — | |
| Calithera Biosciences CALA | $0.0005999 — |
0
|
$2.92K — | $200 — | $0.0001 — | $0.0001 — | $2.92K — | 0 | -$7.94 — | |
| Molecular Templates MTEM | $0.0001 — |
0
|
$658 — | $3 — | $0.0001 — | $0.0001 — | $658 — | 0 | -$3.05 — | |
| NLS Pharmaceutics NLSPW | $0.004499 — |
0
|
$0 — | $4 — | $0.004499 — | $0.004499 — | $0 — | 0 | $0 — | |
| Novo Nordisk A/S N1VO34.SA | $45.89 9.3 USD |
-4.99
|
$1.63T 330.31B USD | $2.37K 480.56 USD | $45.73 9.27 USD | $48.34 9.8 USD | $1.63T 330.31B USD | 18.21 | $2.52 0.51 USD | |
| Novo Nordisk A/S NOVA.F | $54.5 59.58 USD |
-3.71
|
$243.75B 266.45B USD | $1.23K 1.34K USD | $54.5 59.58 USD | $57.1 62.42 USD | $243.75B 266.45B USD | 17.98 | $3.03 3.31 USD | |
| Novo Nordisk A/S NVON.MX | $1,250 74.02 USD |
-3.04
|
$2.88T 170.69B USD | $941 55.72 USD | $1,250 74.02 USD | $1,285 76.09 USD | $2.88T 170.69B USD | 20.13 | $62.09 3.68 USD | |
| Vertex Pharmaceuticals Incorporated VRTX.MX | $10,061.9 595.79 USD |
0
|
$2.59T 153.17B USD | $79 4.68 USD | $10,061.9 595.79 USD | $10,061.9 595.79 USD | $2.59T 153.17B USD | 0 | -$42.25 -2.5 USD | |
| Vertex Pharmaceuticals Incorporated VRTX34.SA | $717.59 145.44 USD |
-2.39
|
$737.91B 149.56B USD | $1 0.2 USD | $717.59 145.44 USD | $717.59 145.44 USD | $737.91B 149.56B USD | 0 | -$3.01 -0.6 USD | |
| Vertex Pharmaceuticals Incorporated VX1.DE | $435.4 475.95 USD |
-1.09
|
$112.24B 122.69B USD | $186 203.32 USD | $432.05 472.29 USD | $441.5 482.62 USD | $112.24B 122.69B USD | 0 | -$1.85 -2.02 USD | |
| Vertex Pharmaceuticals Incorporated VX1.F | $436.4 477.04 USD |
-1.71
|
$112.19B 122.64B USD | $87 95.1 USD | $436.4 477.04 USD | $436.4 477.04 USD | $112.19B 122.64B USD | 0 | -$1.82 -1.9 USD | |
| Vertex Pharmaceuticals Incorporated VRTX.VI | $435.3 475.84 USD |
-1.24
|
$112.07B 122.51B USD | $44 48.1 USD | $432.2 472.45 USD | $441.85 483 USD | $112.07B 122.51B USD | 0 | -$1.85 -2.02 USD | |
| CSL CMXHF | $147.3 — |
-4.97
|
$74.69B — | $526 — | $155 — | $155 — | $74.69B — | 27.02 | $5.45 — | |
| Regeneron Pharmaceuticals, Inc. REGN.MX | $11,544.79 683.59 USD |
<0.01
|
$1.24T 73.49B USD | $0 0 USD | $11,544.79 683.59 USD | $11,544.79 683.59 USD | $1.24T 73.49B USD | 14.97 | $771.19 45.66 USD | |
| Regeneron Pharmaceuticals, Inc. REGN34.SA | $55.72 11.29 USD |
0
|
$359.42B 72.85B USD | $0 0 USD | $55.72 11.29 USD | $55.72 11.29 USD | $359.42B 72.85B USD | 14.89 | $3.74 0.76 USD | |
| CSL Limited CSJ.F | $133.52 145.96 USD |
-1.74
|
$64.72B 70.75B USD | $10 10.93 USD | $133.52 145.96 USD | $134.06 146.55 USD | $64.72B 70.75B USD | 27.75 | $4.81 5.26 USD | |
| CSL Limited CSJA.F | $66 72.15 USD |
-3.65
|
$63.92B 69.87B USD | $6 6.56 USD | $66 72.15 USD | $66 72.15 USD | $63.92B 69.87B USD | 27.49 | $2.4 2.62 USD | |
| Regeneron Pharmaceuticals, Inc. REGN.VI | $490.9 536.62 USD |
-1.23
|
$53.13B 58.08B USD | $0 0 USD | $487.1 532.47 USD | $493.5 539.46 USD | $53.13B 58.08B USD | 14.52 | $33.8 36.95 USD | |
| Samsung Biologics Co.,Ltd. 207940.KS | $1,023,000 772.2 USD |
-1.06
|
$72.81T 54.96B USD | $0 0 USD | $0 0 USD | $0 0 USD | $72.81T 54.96B USD | 0 | $0 0 USD | |
| argenx SE A1RG34.SA | $139.72 28.32 USD |
0
|
$214.92B 43.56B USD | $0 0 USD | $139.72 28.32 USD | $139.72 28.32 USD | $214.92B 43.56B USD | 46.72 | $2.99 0.61 USD | |
| Seagen Inc. S1GE34.SA | $56.7 11.49 USD |
0
|
$214.37B 43.45B USD | $0 0 USD | $0 0 USD | $0 0 USD | $214.37B 43.45B USD | 0 | $0 0 USD | |
| Seagen SGEN | $228.74 — |
0
|
$43.15B — | $0 — | $0 — | $0 — | $43.15B — | 0 | $0 — | |
| Seagen Inc. SGT.F | $208.6 228.03 USD |
0
|
$39.36B 43.02B USD | $0 0 USD | $0 0 USD | $0 0 USD | $39.36B 43.02B USD | 0 | $0 0 USD | |
| argenx SE ARGNF | $697.42 — |
0
|
$42.58B — | $5 — | $695.15 — | $695.15 — | $42.58B — | 54.65 | $12.76 — | |
| Seagen Inc. SGEN.MX | $3,711.48 219.77 USD |
0
|
$700.22B 41.46B USD | $0 0 USD | $0 0 USD | $0 0 USD | $700.22B 41.46B USD | 0 | $0 0 USD | |
| Alnylam Pharmaceuticals, Inc. A1LN34.SA | $67.99 13.78 USD |
-1.82
|
$175.99B 35.67B USD | $38 7.7 USD | $67.99 13.78 USD | $69.79 14.15 USD | $175.99B 35.67B USD | 0 | -$0.64 -0.1 USD | |
| argenx SE ARGX.VI | $528 577.18 USD |
-0.45
|
$32.24B 35.24B USD | $0 0 USD | $523.8 572.58 USD | $528 577.18 USD | $32.24B 35.24B USD | 46.97 | $11.24 12.29 USD | |
| argenx SE 1AE.F | $526.2 575.21 USD |
-0.98
|
$32.13B 35.12B USD | $5 5.47 USD | $526.2 575.21 USD | $526.2 575.21 USD | $32.13B 35.12B USD | 46.69 | $11.27 12.32 USD | |
| argenx SE 1AEA.F | $520 568.43 USD |
-0.95
|
$31.9B 34.87B USD | $6 6.56 USD | $520 568.43 USD | $520 568.43 USD | $31.9B 34.87B USD | 46.05 | $11.29 12.34 USD | |
| UCB SA UNC0.F | $69 75.43 USD |
+1.47
|
$27.48B 30.04B USD | $50 54.66 USD | $69 75.43 USD | $69 75.43 USD | $27.48B 30.04B USD | 25.18 | $2.74 3 USD | |
| UCB SA UCBJF | $150.7 — |
0
|
$29.98B — | $100 — | $150.7 — | $150.7 — | $29.98B — | 24.26 | $6.21 — | |
| UCB SA UNC.F | $141 154.13 USD |
+1
|
$27.35B 29.9B USD | $15 16.4 USD | $141 154.13 USD | $141 154.13 USD | $27.35B 29.9B USD | 25.68 | $5.49 6 USD | |
| Alnylam Pharmaceuticals, Inc. DUL.DE | $227.2 248.36 USD |
0
|
$27.27B 29.81B USD | $0 0 USD | $0 0 USD | $0 0 USD | $27.27B 29.81B USD | 0 | $0 0 USD | |
| UCB SA UCB.VI | $138.65 151.56 USD |
-0.86
|
$26.85B 29.35B USD | $0 0 USD | $138.05 150.91 USD | $140.45 153.53 USD | $26.85B 29.35B USD | 25.30 | $5.48 5.99 USD | |
| Alnylam Pharmaceuticals, Inc. DUL.F | $200.4 219.06 USD |
-4.11
|
$25.94B 28.35B USD | $30 32.79 USD | $200.4 219.06 USD | $200.4 219.06 USD | $25.94B 28.35B USD | 0 | -$1.92 -2.09 USD | |
| BioNTech SE B1NT34.SA | $35.55 7.21 USD |
-1.41
|
$137.42B 27.85B USD | $48 9.73 USD | $35.31 7.16 USD | $35.88 7.27 USD | $137.42B 27.85B USD | 0 | -$1.15 -0.2 USD | |
| BioNTech SE 0A3M.IL | $98 — |
-1.01
|
$26.96B — | $250 — | $97.23 — | $99.16 — | $26.96B — | 5.44 | $18 — | |
| Celltrion, Inc. 068270.KS | $159,100 120.09 USD |
-0.44
|
$34.64T 26.15B USD | $0 0 USD | $0 0 USD | $0 0 USD | $34.64T 26.15B USD | 0 | $0 0 USD | |
| BeiGene, Ltd. 49B.F | $15.33 16.75 USD |
-4.13
|
$23.64B 25.84B USD | $100 109.31 USD | $15.33 16.75 USD | $15.33 16.75 USD | $23.64B 25.84B USD | 0 | -$0.41 -0.4 USD | |
| BeiGene, Ltd. 49BA.F | $202 220.81 USD |
-4.72
|
$23.5B 25.69B USD | $20 21.86 USD | $202 220.81 USD | $204 223 USD | $23.5B 25.69B USD | 0 | -$5.38 -5.8 USD | |
| BeiGene, Ltd. B1GN34.SA | $44.65 9.05 USD |
0
|
$123.42B 25.02B USD | $0 0 USD | $0 0 USD | $0 0 USD | $123.42B 25.02B USD | 0 | $0 0 USD | |
| Genmab A/S GE9.DE | $331 361.83 USD |
0
|
$21.66B 23.68B USD | $0 0 USD | $0 0 USD | $0 0 USD | $21.66B 23.68B USD | 0 | $0 0 USD | |
| BioNTech SE BNTX.VI | $86.9 94.99 USD |
-1.42
|
$20.89B 22.84B USD | $17 18.58 USD | $86.9 94.99 USD | $87.6 95.76 USD | $20.89B 22.84B USD | 0 | -$2.77 -3.02 USD | |
| BioNTech SE 22UA.F | $85 92.92 USD |
-2.86
|
$20.43B 22.34B USD | $250 273.28 USD | $85 92.92 USD | $87.6 95.76 USD | $20.43B 22.34B USD | 0 | -$2.77 -3.02 USD | |
| BeiGene BGNE | $184.72 — |
0
|
$20.21B — | $0 — | $0 — | $0 — | $20.21B — | 0 | $0 — | |
| Royalty Pharma plc RPD.MU | $28.2 30.83 USD |
0
|
$16.44B 17.97B USD | $0 0 USD | $0 0 USD | $0 0 USD | $16.44B 17.97B USD | 16.78 | $1.68 1.84 USD | |
| Royalty Pharma plc RPD.F | $28.16 30.78 USD |
-0.14
|
$16.41B 17.94B USD | $3 3.28 USD | $28.11 30.73 USD | $28.16 30.78 USD | $16.41B 17.94B USD | 16.76 | $1.68 1.84 USD | |
| BioMarin Pharmaceutical Inc. BMRN.MX | $1,480 87.63 USD |
0
|
$283.8B 16.8B USD | $0 0 USD | $1,480 87.63 USD | $1,480 87.63 USD | $283.8B 16.8B USD | 33.33 | $44.4 2.63 USD | |
| BioMarin Pharmaceutical Inc. BM8.DE | $81.02 88.57 USD |
0
|
$15.26B 16.68B USD | $0 0 USD | $0 0 USD | $0 0 USD | $15.26B 16.68B USD | 0 | $0 0 USD | |
| Incyte Corporation I1NC34.SA | $209 42.36 USD |
0
|
$80.89B 16.4B USD | $0 0 USD | $0 0 USD | $0 0 USD | $80.89B 16.4B USD | 475.00 | $0.44 0.09 USD | |
| Incyte Corporation INCY.MX | $1,430.49 84.7 USD |
0
|
$276.83B 16.39B USD | $0 0 USD | $1,430.49 84.7 USD | $1,430.49 84.7 USD | $276.83B 16.39B USD | 476.82 | $3 0.18 USD | |
| BioMarin Pharmaceutical Inc. B1MR34.SA | $208.72 42.3 USD |
0
|
$80.05B 16.22B USD | $0 0 USD | $208.72 42.3 USD | $208.72 42.3 USD | $80.05B 16.22B USD | 32.25 | $6.47 1.31 USD | |
| Genmab A/S GNMSF | $197 — |
+9.35
|
$12.71B — | $182 — | $197 — | $197 — | $12.71B — | 10.68 | $18.44 — | |
| Karuna Therapeutics KRTX | $329.83 — |
0
|
$12.6B — | $0 — | $0 — | $0 — | $12.6B — | 0 | $0 — | |
| Karuna Therapeutics, Inc. KRTX.MX | $3,226.17 191.03 USD |
0
|
$209.06B 12.38B USD | $0 0 USD | $0 0 USD | $0 0 USD | $209.06B 12.38B USD | 0 | $0 0 USD | |
| Insmed Incorporated IM8N.F | $62 67.77 USD |
-0.8
|
$11.31B 12.36B USD | $10 10.93 USD | $62 67.77 USD | $62 67.77 USD | $11.31B 12.36B USD | 0 | -$4.91 -5.3 USD | |
| United Therapeutics Corporation UTH.F | $244.6 267.38 USD |
-1.41
|
$11.12B 12.16B USD | $20 21.86 USD | $244.6 267.38 USD | $244.6 267.38 USD | $11.12B 12.16B USD | 11.25 | $21.73 23.75 USD | |
| Insmed Incorporated IM8N.SG | $60 65.59 USD |
-3.23
|
$11.03B 12.06B USD | $0 0 USD | $60 65.59 USD | $61.5 67.23 USD | $11.03B 12.06B USD | 0 | -$4.91 -5.3 USD | |
| Genmab A/S GMAB.VI | $174.15 190.37 USD |
+0.37
|
$10.9B 11.91B USD | $0 0 USD | $171.3 187.25 USD | $174.15 190.37 USD | $10.9B 11.91B USD | 10.71 | $16.26 17.77 USD | |
| Moderna, Inc. MRNA.MX | $503.7 29.83 USD |
-2.19
|
$199.44B 11.81B USD | $1.8K 106.64 USD | $500 29.61 USD | $515 30.49 USD | $199.44B 11.81B USD | 0 | -$186.5 -11.04 USD | |
| WuXi Biologics (Cayman) WXIBF | $2.74 — |
0
|
$11.09B — | $5.4K — | $2.74 — | $2.74 — | $11.09B — | 24.90 | $0.11 — | |
| BioMarin Pharmaceutical Inc. BM8.F | $52 56.84 USD |
-0.57
|
$10.09B 11.03B USD | $2 2.19 USD | $52 56.84 USD | $52 56.84 USD | $10.09B 11.03B USD | 26.66 | $1.95 2.13 USD | |
| BioMarin Pharmaceutical Inc. BMRN.VI | $52.56 57.46 USD |
-1.05
|
$10.08B 11.02B USD | $0 0 USD | $52.4 57.28 USD | $52.56 57.46 USD | $10.08B 11.02B USD | 26.95 | $1.95 2.13 USD | |
| Ascendis Pharma A/S A1SN34.SA | $54.36 11.02 USD |
0
|
$54.2B 10.99B USD | $0 0 USD | $54.36 11.02 USD | $54.36 11.02 USD | $54.2B 10.99B USD | 0 | -$43.36 -8.7 USD | |
| Incyte Corporation ICY.F | $51.04 55.79 USD |
-1.69
|
$9.88B 10.8B USD | $6 6.56 USD | $51.04 55.79 USD | $51.04 55.79 USD | $9.88B 10.8B USD | 392.61 | $0.13 0.14 USD | |
| Exelixis, Inc. EX9.F | $31.51 34.44 USD |
+0.9
|
$9.1B 9.95B USD | $92 100.57 USD | $31.51 34.44 USD | $31.54 34.48 USD | $9.1B 9.95B USD | 20.32 | $1.55 1.69 USD | |
| WuXi Biologics (Cayman) Inc. 1FW1.F | $4.48 4.9 USD |
-8.57
|
$9.07B 9.91B USD | $10 10.93 USD | $4.48 4.9 USD | $4.48 4.9 USD | $9.07B 9.91B USD | 23.57 | $0.19 0.21 USD | |
| Moderna, Inc. MRNA.VI | $22.69 24.8 USD |
-1.84
|
$8.78B 9.6B USD | $1.2K 1.31K USD | $22.48 24.57 USD | $22.91 25.04 USD | $8.78B 9.6B USD | 0 | -$8.18 -8.9 USD | |
| Moderna, Inc. 0QF.MU | $22.63 24.73 USD |
-3.35
|
$8.75B 9.56B USD | $0 0 USD | $0 0 USD | $0 0 USD | $8.75B 9.56B USD | 0 | -$8.18 -8.9 USD | |
| Bio-Techne Corporation T1CH34.SA | $9.85 2 USD |
-0.3
|
$47.14B 9.56B USD | $24 4.86 USD | $9.85 2 USD | $9.85 2 USD | $47.14B 9.56B USD | 51.84 | $0.19 0.04 USD | |
| Moderna, Inc. 0QF.F | $22 24.05 USD |
-3.38
|
$8.64B 9.45B USD | $161 175.99 USD | $22 24.05 USD | $23.02 25.16 USD | $8.64B 9.45B USD | 0 | -$8.18 -8.9 USD | |
| Akeso, Inc. 4RY.F | $9.4 10.28 USD |
-5.05
|
$8.5B 9.29B USD | $1.09K 1.19K USD | $9.4 10.28 USD | $9.75 10.66 USD | $8.5B 9.29B USD | 0 | -$0.07 -0.07 USD | |
| Innovent Biologics, Inc. 6IB.F | $5.05 5.52 USD |
-6.48
|
$8.37B 9.15B USD | $6.56K 7.17K USD | $5.05 5.52 USD | $5.2 5.68 USD | $8.37B 9.15B USD | 0 | -$0.01 -0.01 USD | |
| ImmunoGen, Inc. IMU.F | $28.74 31.42 USD |
0
|
$8.08B 8.83B USD | $0 0 USD | $0 0 USD | $0 0 USD | $8.08B 8.83B USD | 0 | $0 0 USD | |
|
没有最喜欢的股票
您还没有喜欢的股票，请将其添加到收藏夹以在此处查看 |
||||||||||